Athira Pharma, Inc. (ATHA) Misses Q1 EPS by 5c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q1 EPS of ($0.23), $0.05 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Deutsche Bank Reiterates Buy Rating on Volkswagen AG (VOW:GR) (VWAGY)
• Faraday Future unveils nine robot models, prices start at $9,990
• Texas Capital Securities Downgrades Universal Technical Institute (UTI) to Hold